CLINICAL ROLE -
Daily Exercise Reduces Type 2 Diabetes Risk
Although any amount of exercise is beneficial, exceeding the recommended level produces the most benefits for diabetes patients.
Read More
Trending News Today: Opioid Overdose Drug Offered at Discounted Price
Top news of the day from across the healthcare landscape.
Drug Resistant HIV May Be Overcome With Long-Acting ART
Ibalizumab for multi-drug resistant HIV showed significant promise fighting the disease.
Trending News Today: Link Between Cancer Drugs and Cardiovascular Problems
Top news of the day from across the health care landscape.
Is the United States Health Care System in Trouble?
Xgeva Shows Positive Results in Multiple Myeloma
Xgeva targets the RANK ligand pathways to prevent the creation, function, and survival of osteoclasts.
Opioid-Related Hospitalizations for Children and Teens On the Rise
Children and adolescents are becoming increasingly more likely to be hospitalized for prescription opioid poisoning, a study published in JAMA Pediatrics finds.
Omalizumab Therapy Effective Reducing Angioedema
omalizumab shows efficacy resolving patient-reported angioedema.
Income Growth Not Keeping Pace with Rising Out-of-Pocket Costs
A new report finds that employee contributions to health insurance premiums and deductibles are growing slowly, but individuals have been using a larger portion of their incomes to do so.
How the Human-to-Machine Bond is Transforming Health Care
The biggest problem the United States health care system faces is preventable disease. We do not have enough doctors, nurses, or health coaches to fix it.
Target and Tailor Interventions for HIV
HIV has been an epidemic for 30 years. Initially, the health system relied on behavioral interventions to slow the spread of the virus.
Long-Acting ART Reduces Viral Load in Multi-Drug Resistant HIV
Ibalizumab achieves primary endpoint in decreasing the viral load of patients with drug-resistant HIV.
Development Abandoned on Pfizer PCSK9 Inhibitor
Novel PCSK9 inhibitor bococizumab halted after manufacturer determines limited value.
Pfizer Discontinues Development of PCSK9 Inhibitor
The bococizumab development program and all trials will be discontinued.
Manufacturer Tool Helps Define Value of Cancer Treatment
Eli Lilly and Company will launch a revised version of a tool that tracks the progress of cancer over time.
Positive Results for Bone Drug in Multiple Myeloma
Amgen announces top-line results from trial evaluating Xgeva in multiple myeloma.
Two Distinct Subtypes of Crohn's Disease Influence Therapy Response
New findings reveal 2 subsets of the disease which may have an effect on how the disease responds to standard therapy.
New Treatment Can Potentially Reduce HIV Drug Resistance
Ibalizumab caused 83% of HIV-positive patients to achieve a virologic response.
New Test Determines Genetically-Linked High Cholesterol
LipidSeq can lead to more effective treatments for patients with high cholesterol.
Adjusting Speed of Cancer Cell DNA Repair Vital to Overcome Chemotherapy Resistance
A specific mark in histones speeds up repairs in cancer cells, increasing their resistance to treatment.
Opioid Outreach Program Seeks to Control Epidemic
Presentations and discussions will be held at colleges to combat the opioid epidemic.
Trending News Today: Lymphoma Immunotherapy Technique Shows Promise
Simulation Technique Lends Hope to Promising Anti-Cancer Treatment
A novel approach looks to provide researchers with the tools to make accurate and safe predictions for cancer patients.
Trending News Today: Bronze Healthcare Plan Enrollment Grows
Premiums in employer plans are growing more slowly on average, as are individual income levels.
Phase 2 Trial Launched for Seizure Medication
FYCOMPA is an adjunctive therapy for partial-onset seizures.
Eisai Begins 2 Phase 3 Trials to Further Assess FYCOMPA
Eisai announced the beginning of 2 multi-center, global phase 3 clinical trials assessing FYCOMPA (perampanel).
A Diabetes Success Story
One of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”
Could a Male Birth Control Shot Be on the Horizon?
Although men generally have fewer options for controlling their fertility than women, an investigational hormone shot could provide male patients with a new way to help prevent pregnancy in their female partners.
Over 700 Patients Potentially Affected by Opioid-Stealing Technician
A hospital in Des Moines, Iowa, has notified relevant patients that a former employee may have stolen opioid painkillers intended for them.
